【AI Detection Complete】'Wuhan Pneumonia' Related Stocks 'Bottom Buying Opportunity' Spotted

▶Get the low-buy timing related to Wuhan Pneumonia (Click)

The novel coronavirus, called Wuhan Pneumonia, is causing fear as confirmed cases increase not only worldwide but also domestically.

In China, the number of infected people has already exceeded 10,000, and with more than 20 confirmed cases domestically, concerns about a 'second MERS incident' are growing.

▶Check Wuhan Pneumonia-related stocks you will 100% regret not catching now (Click)

With the spread of the novel coronavirus, stock prices are rising sharply, centered on treatments and hygiene products.

Companies producing sanitizers recorded upper price limits as soon as the first domestic confirmed case appeared, and stocks related to AIDS and malaria treatments are also soaring as it became known that these treatments have effects against the novel coronavirus.

ITBC Stock expert Taeil Ahn, who is proficient in the bio and pharmaceutical fields, said, “As the number of novel coronavirus infections in China increases, interest in treatments is also growing,” adding, “The key is to find the appropriate buying timing as research results related to treatments continue to emerge.”

▶Spread of the novel coronavirus! Check rapidly rising stocks (Click)

Meanwhile, the securities expert broadcast itbc Stock, with 100,000 members, provides beneficiary stock information related to ‘novel coronavirus treatments’ through the link below.

▶View AI-detected novel coronavirus treatment-related stocks (Click)

Related stocks: Woongjin, Monami, Shinpung Pharmaceutical, Naturecell, Luxel

※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.